Nursing care of the client requiring percutaneous coronary intervention

Nursing Clinics of North America

Volumn 39, Issue 4 SPEC. ISS., 2004, Pages 829-844

  Vlasic, Wendy ^a,b,c,d  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^d NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; HIRULOG; THROMBIN INHIBITOR; TICLOPIDINE; WARFARIN;

ANGIOPLASTY; CORONARY ARTERY DISEASE; DIAGNOSTIC PROCEDURE; HEALTH CARE QUALITY; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INTRACARDIAC THROMBOSIS; NEUTROPENIA; NURSING; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; REOPERATION; RESTENOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 9344224593     PISSN: 00296465     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnur.2004.07.007     Document Type: Review

References (18)

1. Keely Primary Angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials Lancet 361 2003 13 20
2. J. Hochman, L. Sleeper, and H. White Early revascularization improves one-year survival for cardiogenic shock complicating acute myocardial infarction: results of the randomized SHOCK Trial JAMA 285 2001 190 192
3. M.S. Sabatine, D.A. Morrow, and R.P. Giugliano Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial Circulation 109 7 2004 874 880
4. S. Marso, A. Lincoff, S. Ellis, D. Bhatt, J. Tanguay, and N. Kleiman Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic sub-study Circulation 100 1999 2477 2484
5. R.A. Corpus, P.B. George, J.A. House, S.R. Dixon, S.C. Ajluni, and W.H. Devlin Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention Am Coll Cardiol 43 1 2004 8 14 7
6. K. Malmberg, S. Yusuf, and H.C. Gerstein Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) registry Circulation 102 2000 1014 1019
7. V. Dzavik, W. Ghali, C. Norris, B. Mitchell, A. Koshal, and D. Saunders Long-term survival in 11,661 patients with multivessel coronary artery disease in the era of stenting: A report from the Alberta Provincial Project for Outcome Assessment in Coronary Heart disease (APPROACH) investigators Am Heart J 141 1 2001 119 126
8. R. Birck, S. Krzossok, and F. Markowtz Acetylcysteine for prevention of contrast nephropathy: meta-analysis Lancet 362 2003 598 603
9. J. Kay, W.H. Chow, and T.M. Chan Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention. A randomized controlled trial JAMA 289 2003 553 558
10. P. Aspelin, P. Aubry, and S.G. Fransson Nephrotoxic effects in high-risk patients undergoing angiography N Engl J Med 348 6 2003 491 499
11. R. Waksman, B. Bhargava, and L. White Intracoronary b-radiation therapy inhibits recurrence of in-stent restenosis Circulation 101 2000 1895 1898
12. M.E. Bertrand, H.J. Rupprecht, and P. Urban Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS) Circulation 102 2000 624 629
13. M. Suliman, L. Gruberg, H. Hammerman, D. Aronson, M. Halabi, and A. Goldberg Comparison of two platelet glycoprotein IIb/IIIa inhibitors, Eptifibatide and Abxicimab: outcomes, complications and thrombocytopenia during percutaneous coronary intervention J Invasive Card 15 6 2003 319 323
14. A.M. Lincoff, J.A. Bittl, R.A. Harrington, and for the REPLACE-2 Investigators Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade compared with Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention REPLACE-2 randomized trial JAMA 289 2003 853 863
15. G. Vetrovec Drug-eluting stents: current outcomes and potential impact on coronary disease management J Invasive Card 14 11 2002 708 712
16. B.J. Rensing, J. Vos, and P.C. Smits Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and ultrasonic follow-up Eur Heart J 22 2001 2125 2130
17. M. Koreny, E. Riedmueller, and M. Nikfardjam Arterial puncture closing devices compared with standard manual compression after cardiac catheterization JAMA 291 2004 350 357
18. W. Vlasic, D. Almond, and D. Massel Reducing Bedrest Following Arterial Puncture for Coronary interventional procedures (BAC trial): impact on vascular complications J Invasive Card 13 12 2001 788 792